Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Clearmind Medicine Inc. (CMND) had Stock-Based Compensation of $1.41M for the most recently reported fiscal quarter, ending 2026-01-31.
| Income Statement Financials | |
-- |
|
$-3.85M |
|
-- |
|
-- |
|
$3.66M |
|
$-3.66M |
|
$-0.19M |
|
$-3.85M |
|
$-3.28M |
|
$-3.85M |
|
$-3.85M |
|
$-3.85M |
|
$-3.28M |
|
$-3.66M |
|
$-3.66M |
|
1.16M |
|
1.16M |
|
$-3.32 |
|
$-3.32 |
|
| Balance Sheet Financials | |
$11.02M |
|
-- |
|
$0.12M |
|
$11.14M |
|
$2.90M |
|
-- |
|
-- |
|
$2.90M |
|
$8.24M |
|
$8.14M |
|
$8.24M |
|
1.50M |
|
| Cash Flow Statement Financials | |
$-2.08M |
|
-- |
|
$7.42M |
|
$3.92M |
|
$9.26M |
|
$5.33M |
|
|
Stock-Based Compensation |
$1.41M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.79 |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-2.08M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-46.79% |
|
-47.33% |
|
-34.59% |
|
-46.79% |
|
$5.49 |
|
$-1.79 |
|
$-1.79 |
|